Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy volunteers, 18 to 65 years of age, inclusive
Healthy volunteers with a stable chronic disease that is not associated with cognitive deficits (e.g. asthma) and does not require any treatment known to affect cognition have to be discussed with the medical monitor before enrollment
A body mass index between 18 to 30 kg/m2 inclusive
Able to participate and willing to give written informed consent and to comply with the study restrictions
At least second generation resident in the country of origin
You may not be if
Current or past history of a psychiatric disorder
Family history of psychiatric disorders
Suspicion or evidence of regular consumption of drugs of abuse or a positive drug test at the screening visit
Acute or chronic disorder which is not stable or may affect cognition or needs treatment affecting cognition
Change of smoking behavior or smoking cessation therapy within 30 days before screening visit
Positive result on hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) 1 and 2
Systolic blood pressure greater than 140 or less than 90 mm Hg, and diastolic blood pressure greater than 100 or less than 50 mm Hg
Resting Pulse Rate greater than 100 or less than 45 beats per minute
Clinically significant abnormalities in laboratory test results or in ECG assessment at screening visit
Participation in an investigational drug study within 1 month prior to baseline